Navigation Links
Biomechanical performances of old-fashioned leather and modern football helmets
Date:5/7/2013

spect to head impact doses and head injury risks at the severity level of subconcussive injury. Rowson and coauthors state that they offer "biomechanical analysis based on helmet testing methodologies that compare relative helmet performance." The source of their disagreement with the Bartsch study centers on the different methods used by the authors of the two studies. Much of the discussion explains how differences in impact testing methodologies can influence the resulting data.

In an editorial companying the paper by Rowson and colleagues ("Editorial. Leather football helmets," by Adam Bartsch, Ph.D., Edward Benzel, M.D., Vincent Miele, M.D., and Vikas Prakash, Ph.D., also published today online, ahead of print in the Journal of Neurosurgery), Dr. Bartsch and colleagues defend the study they published in the Journal of Neurosurgery in 2012 and state that differences in results between the two studies are based on the different testing methodologies used by the two groups of researchers and the resulting head motions that were induced. They state that their study simulated both linear and rotational head motion, whereas the drop test used by Rowson and colleagues provided mainly linear head motion. Bartsch and colleagues reiterate that their data demonstrated test conditions akin to common on-field impact scenarios, which cause both linear and rotational head motion. These researchers call for continued examination of experimental protocols that may lead to better quantification of helmet performance during simulated on-field conditions.

In their response to the editorial, Rowson and colleagues discuss points of difference and agreement between the two sets of researchers and their methodologies.


'/>"/>

Contact: Jo Ann M. Eliason
jaeliason@thejns.org
434-982-1209
Journal of Neurosurgery Publishing Group
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Research breakthrough: High brain integration underlies winning performances
2. New study shows continued decline in the last remaining stronghold for leatherback sea turtles
3. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
4. Ancient whale species sheds new light on its modern relatives
5. Has modern science become dysfunctional?
6. Crime and punishment: The neurobiological roots of modern justice
7. Modern hybrid corn makes better use of nitrogen, study shows
8. Research: Modern Portfolio Theory optimizes conservation practices
9. Squid ink from Jurassic period identical to modern squid ink, U.Va. study shows
10. Woolly mammoth extinction has lessons for modern climate change
11. Fossil egg discovered in Lleida (Spain) links dinosaurs to modern birds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... Transparency Market Research has released ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... is forecast to reach US$ 2,671.8 Mn by 2022. ... systems by civil and government agencies. This is majorly ... activities across the globe that would elevate the demand ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... solutions, today announced that members of the executive management ... Pacific Crest Global Technology Leadership Forum on Tuesday, August ... will be held at the Sonnenalp Resort in ... presentation may include forward-looking information. An audio webcast of ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... the Obesity Institute at Children,s National ... share ideas, failures and successes, and the future ... childhood obesity, both in the District of Columbia ... National seeks to reduce childhood obesity using a ...
... Virginia Tech Wake Forest University,s School of Biomedical Engineering ... Modeling and Simulation Award for 2008. The Office ... Director of the Army presented the award for research that ... associated with facial injury. The center was selected ...
... If you,re looking for bonefish from Miami down to ... from, and that is down slightly from the average ... who are counting, researchers speculate. The University of Miami,s ... sixth annual Florida Keys bonefish census, in conjunction with ...
Cached Biology News:Children's National convenes first childhood obesity symposium 2Children's National convenes first childhood obesity symposium 3Children's National convenes first childhood obesity symposium 4New dummy design and development wins US Department of Defense award 2Bonefish census reveals population holding steady 2
(Date:8/31/2015)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC ... announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd. ... an Investigational New Drug (IND) application for the topical ... completed a study in a rat model of dry ... efficacy and a more rapid onset of action than ...
(Date:8/31/2015)... and SHANGHAI , ... privately-held biopharmaceutical company developing next-generation antibiotics, today announced ... clinical study for its lead drug candidate MRX-I. ... treat drug-resistant bacteria such as MRSA and VRE, ... better tolerated therapeutic option than currently available oxazolidinone ...
(Date:8/31/2015)... Trimb Healthcare AB ("Trimb") today announced that it has ... a Dutch OTC company with operations in key European ... 16 million, with solid growth and leading brands in ... build a leading international OTC company, and this acquisition ... us a stronger North European OTC platform, from which ...
(Date:8/31/2015)... ... 2015 , ... There’s a new treatment option for excessive menstrual bleeding – ... FDA approved system in the last 14 years, and the only endometrial ablation product ... rate of 66%, the high Patient Satisfaction rate of 98%, and the fastest procedure ...
Breaking Biology Technology:Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3
... 2 The Foundation for,Biomedical Research (FBR) congratulates ... DeBakey the highest civilian honor it can bestow, ... to cardiovascular medicine,have improved the health of millions ... extraordinary talents as a surgeon, inventor, educator and,medical ...
... Roche Files CTA for Third Genmab Antibody,Summary: Genmab,s Partner Roche has ... ... Genmab Antibody, COPENHAGEN, October 2 Genmab ... Clinical Trial,Application (CTA) with the British Medicines and Healthcare products,Regulatory Agency ...
... N.J., Oct. 2 Synvista Therapeutics,Inc. (Amex: SYI ... Chief Executive Officer will present at the BIO InvestorForum,2007 ... BIO InvestorForum will,be held on October 9 - 11, ... Dr. Berkowitz will discuss the company,s planned and/or ...
Cached Biology Technology:Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal 2Genmab A/S - Company Announcement 2Synvista Therapeutics to Present at the BIO InvestorForum 2007 2Synvista Therapeutics to Present at the BIO InvestorForum 2007 3
Purified anti-eIF-4E...
Peptide-affinity Purified Polyclonal Antibody to SMAD7 Peptide with sequence SSCPCWLEVIFNSR, from C Terminus of the protein sequence according to NP_005895....
Purified anti-PXR...
Polyclonal Antibody to PRG3...
Biology Products: